SEC Info℠

Home

Search

My Interests

Help

Sign In

Please Sign In

iShares S&P GSCI Commodity-Indexed Trust – ‘10-Q’ for 9/30/23

On:  Friday, 11/3/23, at 2:40pm ET   ·   For:  9/30/23   ·   Accession #:  1437749-23-30199   ·   File #:  1-32947

Previous ‘10-Q’:  ‘10-Q’ on 8/4/23 for 6/30/23   ·   Next & Latest:  ‘10-Q’ on 5/8/24 for 3/31/24   ·   7 References:   To:  iShares S&P GSCI Commodity-Indexed Trust – ‘8-K’ on 4/1/22 for 3/31/22 To:  iShares S&P GSCI Commodity-Indexed Trust – ‘S-3/A’ on 5/24/21 To:  iShares S&P GSCI Commodity-Indexed Trust – ‘POSASR’ on 4/2/14 To:  iShares S&P GSCI Commodity-Indexed Trust – ‘S-3ASR’ on 1/2/14 To:  iShares S&P GSCI Commodity-Indexed Trust – ‘8-K’ on / for 11/29/13 To:  iShares S&P GSCI Commodity-Indexed Trust – ‘8-K’ on / for 5/9/07 To:  iShares S&P GSCI Commodity-Indexed Trust – ‘S-1/A’ on 5/26/06 

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

 Text Wildcards:  ? (any letter/digit),  * (many).  Search Logic:  for Documents:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).  Details... 

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/03/23  iShares S&P GSCI Commodity-In… Tr 10-Q        9/30/23   49:3.5M                                   RDG Filings/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    674K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
11: R1          Document And Entity Information                     HTML     68K 
12: R2          Statements of Assets and Liabilities (Unaudited)    HTML     47K 
13: R3          Statements of Assets and Liabilities (Unaudited)    HTML     27K 
                (Parentheticals)                                                 
14: R4          Statements of Operations (Unaudited)                HTML     78K 
15: R5          Statements of Changes in Net Assets (Unaudited)     HTML     60K 
16: R6          Statements of Cash Flows (Unaudited)                HTML     71K 
17: R7          Schedules of Investments (Unaudited)                HTML     81K 
18: R8          Note 1 - Organization                               HTML     23K 
19: R9          Note 2 - Significant Accounting Policies            HTML     35K 
20: R10         Note 3 - Offering of the Shares                     HTML     24K 
21: R11         Note 4 - Trust Expenses                             HTML     19K 
22: R12         Note 5 - Related Parties                            HTML     21K 
23: R13         Note 6 - Indemnification                            HTML     19K 
24: R14         Note 7 - Commitments and Contingent Liabilities     HTML     18K 
25: R15         Note 8 - Financial Highlights                       HTML     42K 
26: R16         Note 9 - Investing in Index Futures                 HTML     43K 
27: R17         Note 10 - Investment Valuation                      HTML     38K 
28: R18         Insider Trading Arrangements                        HTML     24K 
29: R19         Significant Accounting Policies (Policies)          HTML     49K 
30: R20         Schedules of Investments (Unaudited) (Tables)       HTML     79K 
31: R21         Note 8 - Financial Highlights (Tables)              HTML     39K 
32: R22         Note 9 - Investing in Index Futures (Tables)        HTML     43K 
33: R23         Note 10 - Investment Valuation (Tables)             HTML     30K 
34: R24         Schedules of Investments (Unaudited) - Investments  HTML    135K 
                (Details)                                                        
35: R25         Schedules of Investments (Unaudited) - Investments  HTML    136K 
                (Details) (Parentheticals)                                       
36: R26         Schedules of Investments (Unaudited) - Open S&P     HTML     30K 
                GSCI ER Index Futures Contracts (Details)                        
37: R27         Note 2 - Significant Accounting Policies (Details   HTML     16K 
                Textual)                                                         
38: R28         Note 3 - Offering of the Shares (Details Textual)   HTML     15K 
39: R29         Note 4 - Trust Expenses (Details Textual)           HTML     18K 
40: R30         Note 8 - Financial Highlights - Net Asset Value     HTML     32K 
                and Financial Highlights (Details)                               
41: R31         Note 9 - Investing in Index Futures (Details        HTML     15K 
                Textual)                                                         
42: R32         Note 9 - Investing in Index Futures - Effect of     HTML     23K 
                the Futures Contracts, by Risk Exposure Category,                
                on the Statements of Financial Condition (Details)               
43: R33         Note 9 - Investing in Index Futures - Effect of     HTML     24K 
                the Futures Contracts, by Risk Exposure Category,                
                on the Statements of Operations (Details)                        
44: R34         Note 10 - Investment Valuation - Valuation of the   HTML     28K 
                Trust's Investments by the Fair Value Hierarchy                  
                (Details)                                                        
47: XML         IDEA XML File -- Filing Summary                      XML     82K 
45: XML         XBRL Instance -- gsg20230930_10q_htm                 XML   1.00M 
46: EXCEL       IDEA Workbook of Financial Report Info              XLSX     72K 
 7: EX-101.CAL  XBRL Calculations -- gsg-20230930_cal                XML     68K 
 8: EX-101.DEF  XBRL Definitions -- gsg-20230930_def                 XML    514K 
 9: EX-101.LAB  XBRL Labels -- gsg-20230930_lab                      XML    458K 
10: EX-101.PRE  XBRL Presentations -- gsg-20230930_pre               XML    556K 
 6: EX-101.SCH  XBRL Schema -- gsg-20230930                          XSD    118K 
48: JSON        XBRL Instance as JSON Data -- MetaLinks              199±   316K 
49: ZIP         XBRL Zipped Folder -- 0001437749-23-030199-xbrl      Zip    129K 

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

iShares S&P GSCI™ Commodity-Indexed Trust

Statements of Assets and Liabilities (Unaudited)

At September 30, 2023 and December 31, 2022

See notes to financial statements.

iShares S&P GSCI™ Commodity-Indexed Trust

Statements of Operations (Unaudited)

For the three and nine months ended September 30, 2023 and 2022

See notes to financial statements.

iShares S&P GSCI™ Commodity-Indexed Trust

Statements of Changes in Net Assets (Unaudited)

For the three, six and nine months ended September 30, 2023

See notes to financial statements.

iShares S&P GSCI™ Commodity- Indexed Trust

Statements of Changes in Net Assets (Unaudited)

For the three, six and nine months ended September 30, 2022

See notes to financial statements.

iShares S&P GSCI™ Commodity-Indexed Trust

Statements of Cash Flows (Unaudited)

For the nine months ended September 30, 2023 and 2022

See notes to financial statements.

iShares S&P GSCI™ Commodity-Indexed Trust

Notes to Financial Statements (Unaudited)

September 30, 2023

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This information should be read in conjunction with the financial statements and notes to financial statements included in Item 1 of Part I of this Form 10‑Q. The discussion and analysis that follows may contain statements that relate to future events or future performance. In some cases, such forward‑looking statements can be identified by terminology such as “may,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially. These statements are based upon certain assumptions and analyses made by the Sponsor on the basis of its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. Whether or not actual results and developments will conform to the Sponsor’s expectations and predictions, however, is subject to a number of risks and uncertainties, including the special considerations discussed below, general economic, market and business conditions, changes in laws or regulations, including those concerning taxes, made by governmental authorities or regulatory bodies, and other world economic and political developments. Although the Sponsor does not make forward looking statements unless it believes it has a reasonable basis for doing so, the Sponsor cannot guarantee their accuracy. Except as required by applicable disclosure laws, none of the Trust, the Sponsor, the Advisor, the Trustee or the Delaware Trustee is under a duty to update any of the forward‑looking statements to conform such statements to actual results or to a change in expectations or predictions.

Introduction

The iShares S&P GSCI™ Commodity-Indexed Trust (the “Trust”) is a Delaware statutory trust that issues units of beneficial interest (“Shares”) representing fractional undivided beneficial interests in its net assets. The Trust holds long positions in exchange-traded index futures contracts of various expirations, (“Index Futures”) on the S&P GSCI™ Excess Return Index (the “S&P GSCI-ER”), together with cash, U.S. Treasury securities or other short-term securities and similar securities that are eligible as margin deposits for the Trust’s Index Futures positions, referred to as “Collateral Assets.” The Index Futures held by the Trust are listed on the Chicago Mercantile Exchange (the “CME”). The Trust seeks to track the results of a fully collateralized investment in futures contracts on an index composed of a diversified group of commodities futures. The Trust seeks to track the investment returns of the S&P GSCI™ Total Return Index (the “Index”) before payment of the Trust’s expenses and liabilities.

iShares Delaware Trust Sponsor LLC, a Delaware limited liability company, is the sponsor of the Trust (the “Sponsor”). BlackRock Institutional Trust Company, N.A. is the “Trustee” of the Trust. The Trust is a commodity pool, as defined in the Commodity Exchange Act (the “CEA”) and the applicable regulations of the Commodity Futures Trading Commission (the “CFTC”), and is operated by the Sponsor, a commodity pool operator registered with the CFTC. BlackRock Fund Advisors (the “Advisor”), an indirect subsidiary of BlackRock, Inc., serves as the commodity trading advisor of the Trust and is registered with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940, as amended. The Trust has delegated day-to-day administration of the Trust to the Trustee. The Trustee has delegated certain day-to-day administrative functions of the Trustee to State Street Bank and Trust Company (the “Trust Administrator”). Wilmington Trust Company, a Delaware trust company, serves as the “Delaware Trustee” of the Trust.

The Trust intends to offer Shares on a continuous basis. The Trust issues and redeems Shares only in one or more blocks of 50,000 Shares (“Baskets”). Only institutions that enter into an agreement with the Trust to become “Authorized Participants” may purchase or redeem Baskets, in exchange for Index Futures and Collateral Assets with an aggregate value equal to the net asset value per Share, or “NAV” of the Shares being purchased or redeemed.

Owners of beneficial interests in Shares (“Shareholders”) who are not Authorized Participants have no right to redeem their Shares. In order to liquidate their investment in the Shares, Shareholders who are not Authorized Participants must generally sell their Shares in the secondary market, assuming that demand for their Shares exists. The price obtained by the Shareholders for the Shares may be less than the NAV of those Shares.

Shares of the Trust trade on NYSE Arca, Inc. (“NYSE Arca”) under the ticker symbol GSG.

Valuation of Index Futures; Computation of the Trust’s Net Asset Value

The Sponsor has the exclusive authority to determine the net asset value of the Trust and the NAV, which it has delegated to the Trustee under the Fourth Amended and Restated Trust Agreement. The Trustee determines the net asset value of the Trust and the NAV as of 4:00 p.m. (New York time), on each Business Day on which NYSE Arca is open for regular trading, as soon as practicable after that time. A “Business Day” is a day (1) on which none of the following occurs: (a) NYSE Arca is closed for regular trading, (b) the Exchange is closed for regular trading or (c) the Federal Reserve wire transfer system is closed for cash wire transfers, or (2) that the Trustee determines that it is able to conduct business.

The Trustee values the Trust’s long positions in Index Futures on the basis of that day’s settlement prices for the Index Futures held by the Trust as announced by the applicable Exchange. The value of the Trust’s positions in any particular Index Futures contract equals the product of (1) the number of such Index Futures contracts owned by the Trust, (2) the settlement price of such Index Futures contract on the date of calculation and (3) the multiplier of such Index Futures contract. If there is no announced settlement price for a particular Index Futures contract on a Business Day, the Trustee uses the most recently announced settlement price unless the Trustee, in consultation with the Sponsor, determines that such price is inappropriate as a basis for valuation. The daily settlement price for each Index Futures contract currently held by the Trust is established on each trading day, generally at 2:40 p.m. (New York time), by the CME Group Inc., and its designed contract markets, including the CME, CBOT (Board of Trade of the City of Chicago, Inc.), NYMEX (New York Mercantile Exchange), COMEX and KCBT (the “CME Group”) staff.

The Trustee values all other holdings of the Trust at (1) its current market value, if quotations for such property are readily available or (2) its fair value, as reasonably determined by the Trustee, if the current market value cannot be determined.

Once the value of the Index Futures, Collateral Assets of the Trust and interest earned on the Trust’s Collateral Assets has been determined, the Trustee subtracts all accrued expenses and liabilities of the Trust as of the time of calculation in order to calculate the net asset value of the Trust.

Once the net asset value of the Trust has been calculated, the Trustee determines the NAV by dividing the net asset value of the Trust by the number of Shares outstanding at the time the calculation is made. Any changes to the NAV that may result from creation and redemption activity are not reflected in the NAV calculations for purposes of the Trust’s operations until the Business Day following the Business Day on which they occur, but are reflected in the Trust’s financial statements as of such first Business Day. Creation and redemption orders received after 2:40 p.m. (New York time) are not deemed to be received, and the related creation or redemption will not be deemed to occur, until the following Business Day. Subject to the approval of the Trustee, Baskets may be created solely for cash, but the related creation orders will be deemed received as of the following Business Day unless received by 10:00 a.m. (New York time). Orders are expected to settle by 11:00 a.m. (New York time) on the Business Day following the Business Day on which such orders are deemed to be received.

Results of Operations

The Quarter Ended September 30, 2023

The Trust’s net asset value increased from $992,402,795 at June 30, 2023 to $1,149,755,017 at September 30, 2023. The increase in the Trust’s net asset value resulted primarily from a net increase in net assets resulting from operations. The Trust’s net asset value also benefited from an increase in the number of outstanding Shares, which rose from 50,900,000 Shares at June 30, 2023 to 51,000,000 Shares at September 30, 2023, a consequence of 2,600,000 Shares (52 Baskets) being created and 2,500,000 Shares (50 Baskets) being redeemed during the quarter.

The 15.59% increase in the NAV from $19.50 at June 30, 2023 to $22.54 at September 30, 2023 is directly related to the 14.43% increase in the settlement price for the Index Futures. The NAV increased slightly more than the settlement price for the Index Futures on a percentage basis due to the interest income from U.S. Treasury bills.

The net increase in net assets resulting from operations for the quarter ended September 30, 2023 was $154,105,273, resulting from a net realized and unrealized gain of $142,217,631 and a net investment income of $11,887,642. For the quarter ended September 30, 2023, the Trust had a net realized and unrealized gain of $169,006 on short-term investments and a net realized and unrealized gain of $142,048,625 on futures contracts. Other than the Sponsor’s fees of $2,053,996 and brokerage commissions and fees of $223,882, the Trust had no expenses during the quarter.

The Nine-Month Period Ended September 30, 2023

The Trust’s net asset value decreased from $1,221,109,857 at December 31, 2022 to $1,149,755,017 at September 30, 2023. The decrease in the Trust’s net asset value resulted primarily from a net decrease in the number of outstanding Shares, which fell from 57,550,000 Shares at December 31, 2022 to 51,000,000 Shares at September 30, 2023, a consequence of 4,250,000 Shares (85 Baskets) being created and 10,800,000 Shares (216 Baskets) being redeemed during the period. The Trust’s net asset value benefited from a net increase in net assets resulting from operations.

The 6.22% increase in the Trust’s NAV from $21.22 at December 31, 2022 to $22.54 at September 30, 2023 is directly related to the 3.23% increase in the settlement price for the Index Futures. The Trust’s NAV increased more than the settlement price for the Index Futures on a percentage basis due to the interest income from U.S. Treasury bills.

The net increase in net assets resulting from operations for the period was $58,218,986, resulting from a net realized and unrealized gain of $26,580,822 and a net investment income of $31,638,164. For the nine months ended September 30, 2023, the Trust had a net realized and unrealized loss of $43,318 on short-term investments and a net realized and unrealized gain of $26,624,140 on futures contracts. Other than the Sponsor’s fees of $6,055,752 and brokerage commissions and fees of $683,817, the Trust had no expenses during the period.

Liquidity and Capital Resources

The Trust’s assets as of September 30, 2023 consist of Index Futures and Collateral Assets used to satisfy applicable margin requirements for those Index Futures positions. The Trust does not anticipate any further need for liquidity, because creations and redemptions of Shares generally occur in-kind and ordinary expenses are met by cash on hand. Interest earned on the assets posted as collateral is paid to the Trust and is used to pay the Sponsor’s fees and purchase additional Index Futures and Collateral Assets, or, in the discretion of the Sponsor, distributed to Shareholders. In exchange for a fee based on the net asset value of the Trust, the Sponsor has assumed most of the ordinary expenses incurred by the Trust. In the case of an extraordinary expense and/or insufficient interest income to cover ordinary expenses, however, the Trust could be forced to liquidate its positions in Index Futures and Collateral Assets to pay such expenses. As of September 30, 2023, the market for Index Futures had not developed significant liquidity and the Trust represented substantially all of the long-side open interest in Index Futures. In addition, it is expected that Goldman Sachs & Co. LLC or its accountholders may represent, directly or indirectly, a substantial portion of the short-side interest in such market. The existence of such a limited number of market participants could cause or exacerbate losses to the Trust if the Trust were required to liquidate its Index Futures positions.

The Sponsor is unaware of any other trends, demands, conditions or events that are reasonably likely to result in material changes to the Trust’s liquidity needs.

Because the Trust trades Index Futures, its capital is at risk due to changes in the value of the Index Futures or other assets (market risk) or the inability of counterparties to perform (credit risk).

Market Risk

The Trust holds Index Futures positions and Collateral Assets to satisfy applicable margin requirements on those Index Futures positions. Because of this limited diversification of the Trust’s assets, fluctuations in the value of the Index Futures are expected to directly affect the value of the Shares. The value of the Index Futures is expected to track generally the S&P GSCI-ER, although this correlation may not be exact. The S&P GSCI-ER, in turn, reflects the value of a diversified group of commodities. The Trust’s exposure to market risk will be influenced by a number of factors, including the lack of liquidity of the Index Futures market and activities of other market participants.

Credit Risk

When the Trust purchases or holds Index Futures, it is exposed to the credit risk of a default by the CME’s clearing house, which serves as the counterparty to each Index Futures position, and of a default by its futures commission merchant, or Clearing FCM. In the case of such a default, the Trust may be unable to recover amounts due to it on its Index Futures positions and Collateral Assets posted as margin. The Trust is also exposed to credit risk as a result of its ownership of U.S. Treasury bills or of perceived or actual economic distress or failures of financial institutions.

Off-Balance Sheet Arrangements and Contractual Obligations

The Trust does not use and is not expected to use special purpose entities to facilitate off-balance sheet financing arrangements. The Trust does not have and is not expected to have loan guarantee arrangements or other off-balance sheet arrangements of any kind other than agreements entered into in the normal course of business, which may include indemnification provisions related to certain risks service providers undertake in performing services that are in the interest of the Trust. While the Trust’s exposure under such indemnification provisions cannot be estimated, these general business indemnifications are not expected to have a material impact on the Trust’s financial position.

Critical Accounting Policies

The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements relies on estimates and assumptions that impact the Trust’s financial position and results of operations. These estimates and assumptions affect the Trust’s application of accounting policies. In addition, please refer to Note 2 to the financial statements of the Trust for further discussion of the Trust’s accounting policies.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Quantitative Disclosure

The Trust is exposed to commodity price risk through the Trust’s holdings of Index Futures. The following table provides information about the Trust’s futures contract positions, which are sensitive to changes in commodity prices. As of September 30, 2023, the Trust’s open Index Futures positions (long) were as follows:

The notional amount is calculated using the settlement price for the Index Futures on the CME on September 30, 2023, which was $323.04 per contract, and the $100 multiplier applicable under the contract terms.

The Trust has non-trading market risk as a result of investing in short-term U.S. Treasury bills and such market risk is expected to be immaterial.

Qualitative Disclosure

As described herein, the Trust seeks to track the results of a fully collateralized investment in futures contracts on an index composed of a diversified group of commodities futures. The Trust seeks to track the investment returns of the Index before payment of the Trust’s expenses and liabilities. The Index itself is intended to reflect the performance of a diversified group of physical commodities, including energy commodities, precious and industrial metal commodities, agricultural commodities and livestock commodities. The Trust obtains this exposure to commodity prices through the Trust’s Index Futures positions. As a result, fluctuations in the value of the Trust’s Index Futures are expected to directly affect the value of the Shares.

The Trust will not engage in any activities designed to obtain a profit from, or ameliorate losses caused by, changes in the level of the Index or the S&P GSCI‑ER, or the value of any Collateral Assets. The Trust’s exposure to market risk may be influenced by a number of factors, including the lack of liquidity of the Index Futures market and activities of other market participants.

Item 4. Controls and Procedures

The duly authorized officers of the Sponsor performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, with the participation of the Trustee, have evaluated the effectiveness of the Trust’s disclosure controls and procedures, and have concluded that the disclosure controls and procedures of the Trust were effective as of the end of the period covered by this report to provide reasonable assurance that information required to be disclosed in the reports that the Trust files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to the duly authorized officers of the Sponsor performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, as appropriate to allow timely decisions regarding required disclosure.

There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures.

There were no changes in the Trust’s internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Trust’s internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

There have been no material changes to the Risk Factors last reported under Part I, Item 1A of the registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on February 23, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 6. Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned in the capacities* indicated, thereunto duly authorized.

iShares Delaware Trust Sponsor LLC,

Sponsor of the iShares S&P GSCI™ Commodity-Indexed Trust (registrant)

Shannon Ghia

Director, President and Chief Executive Officer

(Principal executive officer)

Bryan Bowers

Director and Chief Financial Officer

(Principal financial and accounting officer)

*    The registrant is a trust and the persons are signing in their respective capacities as officers of iShares Delaware Trust Sponsor LLC, the Sponsor of the registrant.

---

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing		Date		Other Filings
		12/21/23
		12/15/23
		12/5/23
		11/30/23
		11/28/23
		11/24/23
		11/21/23
		11/14/23
		11/9/23
		11/7/23
Filed on:		11/3/23
		11/2/23
		10/31/23
		10/26/23
		10/24/23
		10/17/23
		10/12/23
		10/10/23
		10/5/23
		10/3/23
For Period end:		9/30/23
		6/30/23		10-Q
		3/31/23		10-Q,  424I
		3/15/23
		2/23/23		10-K
		2/21/23
		2/16/23
		2/14/23
		2/7/23
		1/31/23
		1/26/23
		1/24/23
		1/19/23
		1/17/23
		1/12/23
		1/10/23
		1/5/23
		1/1/23
		12/31/22		10-K
		9/30/22		10-Q
		6/30/22		10-Q
		3/31/22		10-Q,  8-K
		12/31/21		10-K
		7/10/06
		7/7/06
				List all Filings

---

7 Previous Filings that this Filing References

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/01/22 iShares S&P GSCI Commodity-In… Tr 8-K:1,3,9 3/31/22 12:515K RDG Filings/FA 5/24/21 iShares S&P GSCI Commodity-In… Tr S-3/A 5:1.6M RDG Filings/FA 4/02/14 iShares S&P GSCI Commodity-In… Tr POSASR 4/02/14 2:1.1M RDG Filings/FA 1/02/14 iShares S&P GSCI Commodity-In… Tr S-3ASR 1/02/14 9:1.6M RDG Filings/FA 11/29/13 iShares S&P GSCI Commodity-In… Tr 8-K:1,8,9 11/29/13 7:800K RDG Filings/FA 5/09/07 iShares S&P GSCI Commodity-In… Tr 8-K:5,9 5/09/07 3:43K Donnelley … Solutions/FA 5/26/06 iShares S&P GSCI Commodity-In… Tr S-1/A¶ 9:1.5M Donnelley … Solutions/FA

↑Top

---

Filing Submission 0001437749-23-030199   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

---

---

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., May 12, 3:14:14.1am ET